Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes

Noralane M. Lindor, Kimberly A. Schahl, Kiley J. Johnson, Katherine S. Hunt, Kara A. Mensink, Eric D. Wieben, Eric Klee, John L. Black, W. Edward Highsmith, Stephen N. Thibodeau, Matthew J. Ferber, Umut Aypar, Yuan Ji, Rondell P. Graham, Alexander S. Fiksdal, Vivek Sarangi, Kelly E. Ormond, Douglas L. Riegert-Johnson, Tammy M. McAllister, Gianrico FarrugiaJennifer McCormick

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective To understand motivations, educational needs, and concerns of individuals contemplating whole-exome sequencing (WES) and determine what amount of genetic information might be obtained by sequencing a generally healthy cohort so as to more effectively counsel future patients. Patients and Methods From 2012 to 2014, 40 medically educated, generally healthy scientists at Mayo Clinic were invited to have WES conducted on a research basis; 26 agreed to be in a drawing from which 10 participants were selected. The study involved pre- and posttest genetic counseling and completion of 4 surveys related to the experience and outcomes. Whole-exome sequencing was conducted on DNA from blood from each person. Results Most variants (76,305 per person; range, 74,505-77,387) were known benign allelic variants, variants in genes of unknown function, or variants of uncertain significance in genes of known function. The results of suspected pathogenic/pathogenic variants in Mendelian disorders and pharmacogenomic variants were disclosed. The mean number of suspected pathogenic/pathogenic variants was 2.2 per person (range, 1-4). Four pharmacogenomic genes were included for reporting; variants were found in 9 of 10 participants. Conclusion This study provides data that may be useful in establishing reality-based patient expectations, outlines specific points to cover during counseling, and increases confidence in the feasibility of providing adequate preparation and counseling for WES in generally healthy individuals.

Original languageEnglish (US)
Article number1127
Pages (from-to)1327-1337
Number of pages11
JournalMayo Clinic Proceedings
Volume90
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Exome
Counseling
Genes
Pharmacogenetics
Genetic Counseling
Motivation
DNA
Research

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Lindor, N. M., Schahl, K. A., Johnson, K. J., Hunt, K. S., Mensink, K. A., Wieben, E. D., ... McCormick, J. (2015). Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes. Mayo Clinic Proceedings, 90(10), 1327-1337. [1127]. https://doi.org/10.1016/j.mayocp.2015.05.021
Lindor, Noralane M. ; Schahl, Kimberly A. ; Johnson, Kiley J. ; Hunt, Katherine S. ; Mensink, Kara A. ; Wieben, Eric D. ; Klee, Eric ; Black, John L. ; Highsmith, W. Edward ; Thibodeau, Stephen N. ; Ferber, Matthew J. ; Aypar, Umut ; Ji, Yuan ; Graham, Rondell P. ; Fiksdal, Alexander S. ; Sarangi, Vivek ; Ormond, Kelly E. ; Riegert-Johnson, Douglas L. ; McAllister, Tammy M. ; Farrugia, Gianrico ; McCormick, Jennifer. / Whole-Exome Sequencing of 10 Scientists : Evaluation of the Process and Outcomes. In: Mayo Clinic Proceedings. 2015 ; Vol. 90, No. 10. pp. 1327-1337.
@article{152373cb65e54a53bf72630863dde1db,
title = "Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes",
abstract = "Objective To understand motivations, educational needs, and concerns of individuals contemplating whole-exome sequencing (WES) and determine what amount of genetic information might be obtained by sequencing a generally healthy cohort so as to more effectively counsel future patients. Patients and Methods From 2012 to 2014, 40 medically educated, generally healthy scientists at Mayo Clinic were invited to have WES conducted on a research basis; 26 agreed to be in a drawing from which 10 participants were selected. The study involved pre- and posttest genetic counseling and completion of 4 surveys related to the experience and outcomes. Whole-exome sequencing was conducted on DNA from blood from each person. Results Most variants (76,305 per person; range, 74,505-77,387) were known benign allelic variants, variants in genes of unknown function, or variants of uncertain significance in genes of known function. The results of suspected pathogenic/pathogenic variants in Mendelian disorders and pharmacogenomic variants were disclosed. The mean number of suspected pathogenic/pathogenic variants was 2.2 per person (range, 1-4). Four pharmacogenomic genes were included for reporting; variants were found in 9 of 10 participants. Conclusion This study provides data that may be useful in establishing reality-based patient expectations, outlines specific points to cover during counseling, and increases confidence in the feasibility of providing adequate preparation and counseling for WES in generally healthy individuals.",
author = "Lindor, {Noralane M.} and Schahl, {Kimberly A.} and Johnson, {Kiley J.} and Hunt, {Katherine S.} and Mensink, {Kara A.} and Wieben, {Eric D.} and Eric Klee and Black, {John L.} and Highsmith, {W. Edward} and Thibodeau, {Stephen N.} and Ferber, {Matthew J.} and Umut Aypar and Yuan Ji and Graham, {Rondell P.} and Fiksdal, {Alexander S.} and Vivek Sarangi and Ormond, {Kelly E.} and Riegert-Johnson, {Douglas L.} and McAllister, {Tammy M.} and Gianrico Farrugia and Jennifer McCormick",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.mayocp.2015.05.021",
language = "English (US)",
volume = "90",
pages = "1327--1337",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "10",

}

Lindor, NM, Schahl, KA, Johnson, KJ, Hunt, KS, Mensink, KA, Wieben, ED, Klee, E, Black, JL, Highsmith, WE, Thibodeau, SN, Ferber, MJ, Aypar, U, Ji, Y, Graham, RP, Fiksdal, AS, Sarangi, V, Ormond, KE, Riegert-Johnson, DL, McAllister, TM, Farrugia, G & McCormick, J 2015, 'Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes', Mayo Clinic Proceedings, vol. 90, no. 10, 1127, pp. 1327-1337. https://doi.org/10.1016/j.mayocp.2015.05.021

Whole-Exome Sequencing of 10 Scientists : Evaluation of the Process and Outcomes. / Lindor, Noralane M.; Schahl, Kimberly A.; Johnson, Kiley J.; Hunt, Katherine S.; Mensink, Kara A.; Wieben, Eric D.; Klee, Eric; Black, John L.; Highsmith, W. Edward; Thibodeau, Stephen N.; Ferber, Matthew J.; Aypar, Umut; Ji, Yuan; Graham, Rondell P.; Fiksdal, Alexander S.; Sarangi, Vivek; Ormond, Kelly E.; Riegert-Johnson, Douglas L.; McAllister, Tammy M.; Farrugia, Gianrico; McCormick, Jennifer.

In: Mayo Clinic Proceedings, Vol. 90, No. 10, 1127, 01.10.2015, p. 1327-1337.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Whole-Exome Sequencing of 10 Scientists

T2 - Evaluation of the Process and Outcomes

AU - Lindor, Noralane M.

AU - Schahl, Kimberly A.

AU - Johnson, Kiley J.

AU - Hunt, Katherine S.

AU - Mensink, Kara A.

AU - Wieben, Eric D.

AU - Klee, Eric

AU - Black, John L.

AU - Highsmith, W. Edward

AU - Thibodeau, Stephen N.

AU - Ferber, Matthew J.

AU - Aypar, Umut

AU - Ji, Yuan

AU - Graham, Rondell P.

AU - Fiksdal, Alexander S.

AU - Sarangi, Vivek

AU - Ormond, Kelly E.

AU - Riegert-Johnson, Douglas L.

AU - McAllister, Tammy M.

AU - Farrugia, Gianrico

AU - McCormick, Jennifer

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Objective To understand motivations, educational needs, and concerns of individuals contemplating whole-exome sequencing (WES) and determine what amount of genetic information might be obtained by sequencing a generally healthy cohort so as to more effectively counsel future patients. Patients and Methods From 2012 to 2014, 40 medically educated, generally healthy scientists at Mayo Clinic were invited to have WES conducted on a research basis; 26 agreed to be in a drawing from which 10 participants were selected. The study involved pre- and posttest genetic counseling and completion of 4 surveys related to the experience and outcomes. Whole-exome sequencing was conducted on DNA from blood from each person. Results Most variants (76,305 per person; range, 74,505-77,387) were known benign allelic variants, variants in genes of unknown function, or variants of uncertain significance in genes of known function. The results of suspected pathogenic/pathogenic variants in Mendelian disorders and pharmacogenomic variants were disclosed. The mean number of suspected pathogenic/pathogenic variants was 2.2 per person (range, 1-4). Four pharmacogenomic genes were included for reporting; variants were found in 9 of 10 participants. Conclusion This study provides data that may be useful in establishing reality-based patient expectations, outlines specific points to cover during counseling, and increases confidence in the feasibility of providing adequate preparation and counseling for WES in generally healthy individuals.

AB - Objective To understand motivations, educational needs, and concerns of individuals contemplating whole-exome sequencing (WES) and determine what amount of genetic information might be obtained by sequencing a generally healthy cohort so as to more effectively counsel future patients. Patients and Methods From 2012 to 2014, 40 medically educated, generally healthy scientists at Mayo Clinic were invited to have WES conducted on a research basis; 26 agreed to be in a drawing from which 10 participants were selected. The study involved pre- and posttest genetic counseling and completion of 4 surveys related to the experience and outcomes. Whole-exome sequencing was conducted on DNA from blood from each person. Results Most variants (76,305 per person; range, 74,505-77,387) were known benign allelic variants, variants in genes of unknown function, or variants of uncertain significance in genes of known function. The results of suspected pathogenic/pathogenic variants in Mendelian disorders and pharmacogenomic variants were disclosed. The mean number of suspected pathogenic/pathogenic variants was 2.2 per person (range, 1-4). Four pharmacogenomic genes were included for reporting; variants were found in 9 of 10 participants. Conclusion This study provides data that may be useful in establishing reality-based patient expectations, outlines specific points to cover during counseling, and increases confidence in the feasibility of providing adequate preparation and counseling for WES in generally healthy individuals.

UR - http://www.scopus.com/inward/record.url?scp=84943606331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943606331&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2015.05.021

DO - 10.1016/j.mayocp.2015.05.021

M3 - Article

C2 - 26434960

AN - SCOPUS:84943606331

VL - 90

SP - 1327

EP - 1337

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 10

M1 - 1127

ER -

Lindor NM, Schahl KA, Johnson KJ, Hunt KS, Mensink KA, Wieben ED et al. Whole-Exome Sequencing of 10 Scientists: Evaluation of the Process and Outcomes. Mayo Clinic Proceedings. 2015 Oct 1;90(10):1327-1337. 1127. https://doi.org/10.1016/j.mayocp.2015.05.021